Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages en Stemming true Single Family Member false Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

DS:UG

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/1997/014316PACKAGE FOR FOOD PRODUCT AND AN ACCESSORY
WO 24.04.1997
Int.Class A23G 1/00
AHUMAN NECESSITIES
23FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; PREPARATION, TREATMENT OR PRESERVATION THEREOF
GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
1Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
Appl.No PCT/EP1996/004386 Applicant SOREMARTEC S.A. Inventor TERRASI, Giuseppe
The package (1) comprises two half shells (2, 3) having respective mouths in face-to-face relation. One of the half shells (2) contains an edible product (8, 15). The other half shell (3) contains an accessory such as a play element (10).
2.WO/1996/008162CHEWING GUM BASE MANUFACTURING PROCESS USING PLURALITY OF LUBRICATING AGENTS FEED INLETS
WO 21.03.1996
Int.Class A23G 4/00
AHUMAN NECESSITIES
23FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; PREPARATION, TREATMENT OR PRESERVATION THEREOF
GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
4Chewing gum
Appl.No PCT/US1995/003231 Applicant WM. WRIGLEY JR. COMPANY Inventor SONG, Joo, H.
A process for continuously producing a chewing gum base comprises the steps of continuously adding a hard elastomer, a filler and lubricating agents into a continuous (10), subjecting the elastomer, filler and lubricating agents to a dispersive mixing operation and followed by a distributive mixing operation and continuously discharging the resulting chewing gum base from the mixer while the adding and mixing steps are in progress. The lubricating agents are introduced into the continuous mixer at a plurality of spatially separated feed inlets (12, 13, 14 and 15). Preferably part of the lubricating agents are introduced into the mixer with the hard elastomer and the filler prior to the dispersive mixing zone, and a portion of the lubricating agents are introduced into the mixer downstream of the dispersive mixing zone but prior to the distributive mixing zone.
3.WO/2002/064081HERBAL/MEDICATION FOR THE IMPROVEMENT OF AIDS PATIENTS
WO 22.08.2002
Int.Class A61K 36/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Appl.No PCT/SD2001/000002 Applicant IZZELDIN, Hilmi, Sidahmed Inventor IZZELDIN, Hilmi, Sidahmed
No available specific tests for HIV Investigators detection of antibodies in the blood, it is an indirect method of detection. So if the physician expected that a certain person has the disease he request a certain test to be done to prove or exclude the presence of the virus. In the same time there is a test to prove that the patient in who has been given treatment for example become Ok since by the same test which proved that he is positive the patient will continue to give positive test, since the antibodies will remain in his blood for years. The antibodies in the majority of diseases usually give immunity but not in case HIV, it is an indication that the person in question is harboring the virus. Uptill now no curative treatment for HIV. Several drugs has been introduced for this purpose, but their effect is not sure. May be they elongate the life free of symptoms but their side-effects are greater than the benefit. For example AZT causes aneamia and the patient needs the VIH patient. May be it elongate his life. In case of my medication I did not notice any side effects on those who took it Contrary to the drugs used, in case of my drug the patient gains appetite, the haemoglobin rises, his weight increases, and they resume their normal work without external support. In the attached report one can notice the improvement in the cases included as dated advance.
4.WO/1996/013166METHOD FOR TREATING ANXIETY
WO 09.05.1996
Int.Class A61K 31/439
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
439the ring forming part of a bridged ring system, e.g. quinuclidine
Appl.No PCT/US1995/014049 Applicant ELI LILLY AND COMPANY Inventor BODICK, Neil, Clayton
The present invention provides a method for treating anxiety in humans using heterocyclic compounds.
5.WO/1996/009041BENZOTHIOPHENE COMPOUNDS, COMPOSITIONS, AND METHODS
WO 28.03.1996
Int.Class A61K 31/381
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
38having sulfur as a ring hetero atom
381having five-membered rings
Appl.No PCT/US1995/012350 Applicant ELI LILLY AND COMPANY Inventor BRYANT, Henry, Uhlman
The present invention provides novel benzothiophene compounds, pharmaceutical formulations, and processes for preparation thereof, and methods of using such compounds for alleviating the symptoms of post-menopausal syndrome and inhibiting endometriosis, uterine fibrosis, and smooth muscle cell proliferation.
6.WO/1996/0110065-HT1F MEDIATED INHIBITION OF NEUROGENIC MENINGEAL EXTRAVASATION
WO 18.04.1996
Int.Class A61K 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
31Medicinal preparations containing organic active ingredients
Appl.No PCT/US1995/013010 Applicant ELI LILLY AND COMPANY Inventor AUDIA, James, Edmund
The present invention provides a method for the treatment of migraine and associated disorders which relies on a novel mechanism of action. By treating a migraineur with compounds or compositions which are selective agonists of 5-HT1F receptors relative to other serotonin receptors which produce unwanted effects like vasoconstriction, the neurogenic meningeal extravasation which leads to the pain of migraine is inhibited and the physiological liabilities of compounds exhibiting vasoconstriction or other side effects are avoided.
7.WO/2002/089216METHOD FOR INCREASING THE OUTPUT POWER OF PHOTOVOLTAIC CELLS
WO 07.11.2002
Int.Class F24S 23/30
FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
24HEATING; RANGES; VENTILATING
SSOLAR HEAT COLLECTORS; SOLAR HEAT SYSTEMS
23Arrangements for concentrating solar rays for solar heat collectors
30with lenses
Appl.No PCT/DZ2001/000004 Applicant HIHI, Bachir Inventor HIHI, Bachir
The invention concerns a method for increasing the output power of any photovoltaic cell using a linear concentration by means of a mutliprism and for using a special transparent film which can absorb up to 93 % of ultraviolet rays so that the temperature at the surface of the photovoltaic cells is acceptable.
8.WO/1996/024356METHODS OF INHIBITING EFFECTS OF IL-6
WO 15.08.1996
Int.Class A61K 31/4025
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
4025not condensed and containing further heterocyclic rings, e.g. cromakalim
Appl.No PCT/US1996/001621 Applicant ELI LILLY AND COMPANY Inventor GLASEBROOK, Andrew, L.
A method of inhibiting the effects of IL-6 comprising administering to a human in need thereof an effective amount of a compound having formula (I) wherein R1 and R3 are independently hydrogen, -CH3, (a), or (b), wherein Ar is optionally substituted phenyl; R2 is selected from the group consisting of pyrrolidine, hexamethyleneimino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
9.WO/1995/029940CATIONIC CATALYSTS AND PROCESS FOR USING SAID CATALYSTS
WO 09.11.1995
Int.Class C08F 4/619
CCHEMISTRY; METALLURGY
08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
4Polymerisation catalysts
42Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors
44selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths, or actinides
60together with refractory metals, iron group metals, platinum group metals, manganese, technetium, rhenium, or compounds thereof
619Component covered by group C08F4/6055
Appl.No PCT/US1995/005302 Applicant EXXON CHEMICAL PATENTS INC. Inventor SHAFFER, Timothy, Daniel
A cationic catalyst composition comprising a reactive cation and a compatible non-coordinating anion is preferably used at a temperature of 20 °C or less to produce olefin polymers, particularly polymers and copolymers of isobutylene.
10.WO/1995/025844HEAT TREATED HIGH LIGNIN CONTENT CELLULOSIC FIBERS
WO 28.09.1995
Int.Class A61L 15/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
15Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
22containing macromolecular materials
28Polysaccharides or their derivatives
Appl.No PCT/US1995/002983 Applicant THE PROCTER & GAMBLE COMPANY Inventor NAIENI, Shahrokh, A.
Heat-treated-in-air high lignin content cellulosic fibers which are free of moieties from crosslinking agents, for use in absorbent structures, are prepared by fluffing high lignin content fibers at a consistency of at least 40 %, and heating in air at atmospheric pressure at a temperature ranging from 120 °C to 280 °C fluffed fiber water admixture having a consistency of at least 60 % of moisture-free fluffed fibers, to remove any moisture content and heat treat the resulting moisture-free high lignin content fibers for at least 5 seconds, or by heating a sheet of dry (0-40 % moisture content) high lignin content fibers utilizing these same heating conditions and then fluffing.